Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2010

01-12-2010 | Original Article

Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings

Authors: Mohamed Ismail Abd-Elkareem, Hegazy Mogahed Al Tamimy, Osama A. Khamis, Salama S. Abdellatif, Mahmoud Rezk Abdelwahed Hussein

Published in: Clinical and Experimental Nephrology | Issue 6/2010

Login to get access

Abstract

Background

Leukocyte adhesion molecules are important for migration of the inflammatory cells into sites of inflammation. Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are members of the immunoglobulin superfamily that are expressed in normal kidney. Their expression is up-regulated in the renal tissue of patients with lupus nephritis (LN).

Objectives

We evaluated whether changes in urinary levels of ICAM-1 and VCAM-1 reflect renal tissue damage in LN. We related the levels of these molecules to other laboratory findings, especially complement C3/C4 levels. We also tested the hypothesis that changes in urinary levels of ICAM-1 and VCAM-1 reflect the severity of renal tissue damage in LN.

Patients and methods

This study included 30 systemic lupus erythematosus (SLE) patients with LN (16 with mild histological changes, i.e., with World Health Organization (WHO) class I and II LN, and 14 with advanced histological changes, i.e., class III, IV, and V LN) and 20 with SLE without nephritis. In addition, 20 healthy individuals of comparable age were included as a control group. The levels of urinary ICAM-1 and VCAM-1 were measured by enzyme-linked immunosorbent assay (ELISA) and related to the clinical, laboratory [rheumatoid factor(RF), antinuclear antibodies (ANA), anti-double-stranded DNA (anti-dsDNA), complements C3 and C4] and histological findings.

Results

Levels of urinary ICAM-1 and VCAM-l in LN patients with advanced histological changes (renal damage) were statistically significantly higher than those in other groups (LN patients with mild histological changes or SLE patients without nephritis and control group; p < 0.01). In contrast, serum levels of C3 and C4 in LN patients with advanced histological changes were significantly lower than those in other groups (p < 0.01). There was a significant negative correlation between the levels of urinary adhesion molecules and serum complement levels (p < 0.01).

Conclusions

The significantly high urinary levels of the adhesion molecules in the LN group with advanced histological changes may reflect their renal tissue expression and therefore the severity of the nephritis. Renal tissue damage in these cases may be the result of transmigration of activated inflammatory cells, inducing serious tissue damage. The hypocomplementemia combined with increased urinary levels of adhesion molecules seems to be a useful biomarker of disease severity in LN.
Literature
2.
3.
go back to reference Norman MU, James WG, Hickey MJ. Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice. J Leukoc Biol. 2008;84(1):68–76.CrossRefPubMed Norman MU, James WG, Hickey MJ. Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice. J Leukoc Biol. 2008;84(1):68–76.CrossRefPubMed
4.
go back to reference Lhotta K, Neumayer HP, Joannidis M, Geissler D, Konig P. Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. Clin Sci (Lond). 1991;81(4):477–81. Lhotta K, Neumayer HP, Joannidis M, Geissler D, Konig P. Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. Clin Sci (Lond). 1991;81(4):477–81.
5.
go back to reference Chen X, Xu Q, Tang L. Expression of intercellular adhesion molecule-1 and vascular adhesion molecule-1 in kidney of patients with lupus nephritis and membranoproliferative glomerulonephritis. Zhonghua Bing Li Xue Za Zhi. 1995;24(3):149–51.PubMed Chen X, Xu Q, Tang L. Expression of intercellular adhesion molecule-1 and vascular adhesion molecule-1 in kidney of patients with lupus nephritis and membranoproliferative glomerulonephritis. Zhonghua Bing Li Xue Za Zhi. 1995;24(3):149–51.PubMed
6.
go back to reference Zheng L, Sinniah R, Hsu SI. In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy. Virchows Arch. 2006;448(2):172–83.CrossRefPubMed Zheng L, Sinniah R, Hsu SI. In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy. Virchows Arch. 2006;448(2):172–83.CrossRefPubMed
7.
go back to reference Yokoyama H, Takaeda M, Wada T, Ohta S, Hisada Y, Segawa C, Furuichi K, Kobayashi K. Glomerular ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis. Nephron. 1997;76(4):425–33.CrossRefPubMed Yokoyama H, Takaeda M, Wada T, Ohta S, Hisada Y, Segawa C, Furuichi K, Kobayashi K. Glomerular ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis. Nephron. 1997;76(4):425–33.CrossRefPubMed
8.
go back to reference Ma L, Zou W, Zhang Z. In situ expression of intercellular adhesion molecule-1 in human glomerulonephritis. Zhonghua Yi Xue Za Zhi. 1995;75(4):201–3, 253 (Article in Chinese). Ma L, Zou W, Zhang Z. In situ expression of intercellular adhesion molecule-1 in human glomerulonephritis. Zhonghua Yi Xue Za Zhi. 1995;75(4):201–3, 253 (Article in Chinese).
9.
go back to reference Rabb H, O’Meara YM, Maderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 1997;51(5):1463–8.CrossRefPubMed Rabb H, O’Meara YM, Maderna P, Coleman P, Brady HR. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 1997;51(5):1463–8.CrossRefPubMed
10.
go back to reference Wuthrich RP. Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney. J Am Soc Nephrol. 1992;3(6):1201–11.PubMed Wuthrich RP. Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney. J Am Soc Nephrol. 1992;3(6):1201–11.PubMed
11.
go back to reference Henseleit U, Steinbrink K, Sunderkotter C, Goebeler M, Roth J, Sorg C. Expression of murine VCAM-1 in vitro and in different models of inflammation in vivo: correlation with immigration of monocytes. Exp Dermatol. 1995;4(5):249–56.PubMed Henseleit U, Steinbrink K, Sunderkotter C, Goebeler M, Roth J, Sorg C. Expression of murine VCAM-1 in vitro and in different models of inflammation in vivo: correlation with immigration of monocytes. Exp Dermatol. 1995;4(5):249–56.PubMed
12.
go back to reference Seron D, Cameron JS, Haskard DO. Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant. 1991;6(12):917–22.PubMed Seron D, Cameron JS, Haskard DO. Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant. 1991;6(12):917–22.PubMed
13.
go back to reference Wuthrich RP. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int. 1992;42(4):903–14.CrossRefPubMed Wuthrich RP. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int. 1992;42(4):903–14.CrossRefPubMed
14.
go back to reference McLigeyo SO. Pathogenesis of lupus nephritis: a review. East Afr Med J. 1998;75(11):628–31.PubMed McLigeyo SO. Pathogenesis of lupus nephritis: a review. East Afr Med J. 1998;75(11):628–31.PubMed
16.
go back to reference Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology. 1998;199(2):265–85.PubMed Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology. 1998;199(2):265–85.PubMed
17.
go back to reference ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 1990;33(5):634–43.CrossRefPubMed ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 1990;33(5):634–43.CrossRefPubMed
18.
go back to reference Bao L, Quigg RJ. Complement in lupus nephritis: the good, the bad, and the unknown. Semin Nephrol. 2007;27(1):69–80.CrossRefPubMed Bao L, Quigg RJ. Complement in lupus nephritis: the good, the bad, and the unknown. Semin Nephrol. 2007;27(1):69–80.CrossRefPubMed
19.
go back to reference Wuthrich RP, Jevnikar AM, Takei F, Glimcher LH, Kelley VE. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol. 1990;136(2):441–50.PubMed Wuthrich RP, Jevnikar AM, Takei F, Glimcher LH, Kelley VE. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol. 1990;136(2):441–50.PubMed
20.
go back to reference Pallis M, Robson DK, Haskard DO, Powell RJ. Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis. 1993;52(9):667–71.CrossRefPubMed Pallis M, Robson DK, Haskard DO, Powell RJ. Distribution of cell adhesion molecules in skeletal muscle from patients with systemic lupus erythematosus. Ann Rheum Dis. 1993;52(9):667–71.CrossRefPubMed
21.
go back to reference Belmont HM, Buyon J, Giorno R, Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum. 1994;37(3):376–83.CrossRefPubMed Belmont HM, Buyon J, Giorno R, Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum. 1994;37(3):376–83.CrossRefPubMed
22.
go back to reference Ilic T, Mitic I, Durdevic-Mirkovic T, Vuckovic B, Milic B, Popovic M. Correlation between sera levels of sICAM-1 and sVCAM-1 and severity of kidney lesions in patients with lupus nephritis. Med Pregl. 2007;60(Suppl 2):128–32.PubMed Ilic T, Mitic I, Durdevic-Mirkovic T, Vuckovic B, Milic B, Popovic M. Correlation between sera levels of sICAM-1 and sVCAM-1 and severity of kidney lesions in patients with lupus nephritis. Med Pregl. 2007;60(Suppl 2):128–32.PubMed
23.
go back to reference Sabry A, Sheashaa H, El-Husseini A, El-Dahshan K, Abdel-Rahim M, Elbasyouni SR. Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis. Clin Rheumatol. 2007;26(11):1819–23.CrossRefPubMed Sabry A, Sheashaa H, El-Husseini A, El-Dahshan K, Abdel-Rahim M, Elbasyouni SR. Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis. Clin Rheumatol. 2007;26(11):1819–23.CrossRefPubMed
24.
go back to reference Molad Y, Miroshnik E, Sulkes J, Pitlik S, Weinberger A, Monselise Y. Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clin Exp Rheumatol. 2002;20(3):403–6.PubMed Molad Y, Miroshnik E, Sulkes J, Pitlik S, Weinberger A, Monselise Y. Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clin Exp Rheumatol. 2002;20(3):403–6.PubMed
25.
go back to reference Tan PL, Borman GB, Wigley RD. Testing clinical criteria for systemic lupus erythematosus in other connective tissue disorders. Rheumatol Int. 1981;1(3):147–9.CrossRefPubMed Tan PL, Borman GB, Wigley RD. Testing clinical criteria for systemic lupus erythematosus in other connective tissue disorders. Rheumatol Int. 1981;1(3):147–9.CrossRefPubMed
26.
go back to reference Berggård I, Bearn AG. Isolation and properties of a low molecular weight β2-globulin occurring in human biological fluids. J Biol Chem. 1968;243:4095–103. Berggård I, Bearn AG. Isolation and properties of a low molecular weight β2-globulin occurring in human biological fluids. J Biol Chem. 1968;243:4095–103.
27.
go back to reference Bazari H. Approach to the patient with renal disease. In: Goldman L, Ausiello D, editors. Cecil medicine. 23rd ed. Philadelphia: Saunders/Elsevier; 2007:chap 115. Bazari H. Approach to the patient with renal disease. In: Goldman L, Ausiello D, editors. Cecil medicine. 23rd ed. Philadelphia: Saunders/Elsevier; 2007:chap 115.
28.
go back to reference Evenson MA. Report: criteria for analytical instrumentation in a clinical analysis laboratory. Anal Chem. 1979;51:1411A–3A. Evenson MA. Report: criteria for analytical instrumentation in a clinical analysis laboratory. Anal Chem. 1979;51:1411A–3A.
29.
go back to reference Ledue TB, Johnson AM, Cohen LA, Ritchie RF. Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins. Clin Chem. 1998;44:878–9. Ledue TB, Johnson AM, Cohen LA, Ritchie RF. Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins. Clin Chem. 1998;44:878–9.
30.
go back to reference Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 1998;35:745–53. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem. 1998;35:745–53.
31.
go back to reference Tesar V, Masek Z, Rychlik I, Merta M, Bartunkova J, Stejskalova A, Zabka J, Janatkova I, Fucikova T, Dostal C, Becvar R. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant. 1998;13(7):1662–7.CrossRefPubMed Tesar V, Masek Z, Rychlik I, Merta M, Bartunkova J, Stejskalova A, Zabka J, Janatkova I, Fucikova T, Dostal C, Becvar R. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant. 1998;13(7):1662–7.CrossRefPubMed
32.
go back to reference Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N, Calixto S, Mackay M, Aranow C, Putterman C, Mohan C. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol. 2007;179(10):7166–75.PubMed Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N, Calixto S, Mackay M, Aranow C, Putterman C, Mohan C. Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol. 2007;179(10):7166–75.PubMed
33.
go back to reference Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol. 1994;97(3):439–44.CrossRefPubMed Spronk PE, Bootsma H, Huitema MG, Limburg PC, Kallenberg CG. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol. 1994;97(3):439–44.CrossRefPubMed
34.
go back to reference Tesar V, Masek Z, Rychlik I, Merta M, Bartunkova J, Stejskalova A, Zabka J, Fucikova T, Dostal C, Becvar R. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Cas Lek Cesk. 1997;136(16):501–6.PubMed Tesar V, Masek Z, Rychlik I, Merta M, Bartunkova J, Stejskalova A, Zabka J, Fucikova T, Dostal C, Becvar R. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Cas Lek Cesk. 1997;136(16):501–6.PubMed
35.
go back to reference Arrizabalaga Clemente P. Adhesion molecules and glomerulonephritis. Towards novel therapeutic strategies. Med Clin (Barc). 2002;119(4):145–8. Arrizabalaga Clemente P. Adhesion molecules and glomerulonephritis. Towards novel therapeutic strategies. Med Clin (Barc). 2002;119(4):145–8.
36.
go back to reference Wang XC, Feng J, Huang F, Fan YS, Wang YY, Cao LY, Wen CP. Effects of Shikonin isolated from Zicao on lupus nephritis in NZB/W F1 mice. Biol Pharm Bull. 2009;32(9):1565–70.CrossRefPubMed Wang XC, Feng J, Huang F, Fan YS, Wang YY, Cao LY, Wen CP. Effects of Shikonin isolated from Zicao on lupus nephritis in NZB/W F1 mice. Biol Pharm Bull. 2009;32(9):1565–70.CrossRefPubMed
37.
go back to reference Brey RL, Amato AA, Kagan-Hallet K, Rhine CB, Stallworth CL. Anti-intercellular adhesion molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice. Lupus. 1997;6(8):645–51.CrossRefPubMed Brey RL, Amato AA, Kagan-Hallet K, Rhine CB, Stallworth CL. Anti-intercellular adhesion molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice. Lupus. 1997;6(8):645–51.CrossRefPubMed
38.
go back to reference Kootstra CJ, Van Der Giezen DM, Van Krieken JH, De Heer E, Bruijn JA. Effective treatment of experimental lupus nephritis by combined administration of anti-CD11a and anti-CD54 antibodies. Clin Exp Immunol. 1997;108(2):324–32.CrossRefPubMed Kootstra CJ, Van Der Giezen DM, Van Krieken JH, De Heer E, Bruijn JA. Effective treatment of experimental lupus nephritis by combined administration of anti-CD11a and anti-CD54 antibodies. Clin Exp Immunol. 1997;108(2):324–32.CrossRefPubMed
39.
go back to reference Kuroiwa T, Lee EG. Cellular interactions in the pathogenesis of lupus nephritis: the role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus. 1998;7(9):597–603.CrossRefPubMed Kuroiwa T, Lee EG. Cellular interactions in the pathogenesis of lupus nephritis: the role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus. 1998;7(9):597–603.CrossRefPubMed
40.
go back to reference Brady HR. Leukocyte adhesion molecules: potential targets for therapeutic intervention in kidney diseases. Curr Opin Nephrol Hypertens. 1993;2(2):171–82.CrossRefPubMed Brady HR. Leukocyte adhesion molecules: potential targets for therapeutic intervention in kidney diseases. Curr Opin Nephrol Hypertens. 1993;2(2):171–82.CrossRefPubMed
41.
go back to reference Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M, Fine DM. Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol. 2007;34:332–5. Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M, Fine DM. Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol. 2007;34:332–5.
Metadata
Title
Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings
Authors
Mohamed Ismail Abd-Elkareem
Hegazy Mogahed Al Tamimy
Osama A. Khamis
Salama S. Abdellatif
Mahmoud Rezk Abdelwahed Hussein
Publication date
01-12-2010
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2010
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0322-z

Other articles of this Issue 6/2010

Clinical and Experimental Nephrology 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.